Get access to our best features
Get Started
Subscribe
Israeli-Palestinian Conflict
NFL
2024 US Election
Baseball
Donald Trump
US Politics
US Economy
Joe Biden
US Social Issues
US Crime
Republican Party
Senate
Patriots
Get access to our best features
Get Started
Published 2 years ago

Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update

Summary by Ground News
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) today reported its financial results and provided a business update for the second quarter ended June 30, 2022. On track to report topline data from revumenib and axatilimab pivotal programs starting in 1H23. Updated data from Phase 1 portion of AUGMENT-101 trial expected in 4Q22. Company to host conference call today at 4:30 p.m. ET.

0 Articles

All
Left
Center
Right
Business WireBusiness Wire

Reata Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a clinical-stage biopharmaceutical company, today announced

2 years ago·Crystal River, United States
Read Full Article
PR NewswirePR Newswire

Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update

/PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an...

2 years ago·United States
Read Full Article
Globe NewswireGlobe Newswire

Mersana Therapeutics Provides Business Update and Announces Second Quarter 2022 Financial Results

Approaching full enrollment in UPLIFT clinical trial; initiated patient screening in UP-NEXT clinical trialCleared INDs for XMT-1660 and XMT-2056Enhanced...

2 years ago
Read Full Article
docoh.comdocoh.com

Annexon 8K Biosciences Highlights Business and Portfolio Progress and Key Anticipated Milestones and Reports Second Quarter 2022 Financial Results | ANNX 8 Aug 22

Annexon Biosciences Highlights Business and Portfolio Progress and Key Anticipated Milestones and Reports Second Quarter 2022 Financial Results, 8-K SEC filing by Annexon on 8 Aug 22, 4:30pm

2 years ago
Read Full Article
Latest Digital Transformation Trends | Cloud News | Wire19Latest Digital Transformation Trends | Cloud News | Wire19

Desktop Metal Announces Second Quarter 2022 Financial Results - Latest Digital Transformation Trends

Record revenue of $57.7 million, up 204% from second quarter 2021, and an increase of 32% sequentially from first quarter 2022 GAAP gross margin of 14.6%; non-GAAP gross margin of 26.7%, increasing over 170 basis points from second quarter 2021 Announced Strategic Integration and Cost Optimization Initiative to accelerate AM 2.0 growth, support path to profitability, and drive value to shareholders Unveiled FreeFoam, a revolutionary, expandable …

2 years ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal